摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-nitro-benzenesulfonyl bromide | 1950-72-7

中文名称
——
中文别名
——
英文名称
2-nitro-benzenesulfonyl bromide
英文别名
2-Nitro-benzolsulfonylbromid;o-Nitrobenzo-sulfobromid;2-Nitrobenzenesulfonyl bromide
2-nitro-benzenesulfonyl bromide化学式
CAS
1950-72-7
化学式
C6H4BrNO4S
mdl
——
分子量
266.072
InChiKey
VHOGAUNEODDEKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    63-64 °C
  • 沸点:
    400.5±47.0 °C(Predicted)
  • 密度:
    1.904±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    88.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • METHOD FOR PRODUCING AMINO ACID DERIVATIVES
    申请人:API CORPORATION
    公开号:US20210403427A1
    公开(公告)日:2021-12-30
    The present invention aims to provide a method for producing a (2S,5R)-5-(protected oxyamino)-piperidine-2-carboxylic acid derivative at a low cost that can be performed under mild reaction conditions not requiring a facility at an extremely low temperature, is safer, can control the quality of the desired product with ease, and shows good workability in the site of production. A method for producing a compound represented by the formula (2): wherein PG 1 is an amino-protecting group, PG 2 is an amino-protecting group, PG 3 is a hydroxyl-protecting group, LG is a leaving group, and R is a hydrocarbon group having 1-8 carbon atoms and optionally having substituent(s), including a step of reacting a compound represented by the formula (1): wherein each symbol is as defined above, with a hydroxylamine derivative represented by the formula PG 2 NHOPG 3 wherein each symbol is as defined above, in the presence of a base in a solvent.
    本发明旨在提供一种低成本的方法,用于在温和反应条件下生产(2S,5R)-5-(保护氧氨基)-哌啶-2-羧酸衍生物,不需要极低温度设施,更安全,并且可以轻松控制所需产品的质量,在生产现场具有良好的可操作性。该方法包括以下步骤:与公式(1)所表示的化合物在溶剂中反应,其中PG1是氨基保护基,PG2是氨基保护基,PG3是羟基保护基,LG是离去基团,R是具有1-8个碳原子的烃基,并且可选地具有取代基,与公式PG2NHOPG3所表示的羟胺衍生物在碱的存在下反应。
  • NOVEL CRYSTALLINE ARYLALKYLAMINE COMPOUND AND PROCESS FOR PRODUCING THE SAME
    申请人:MITSUBISHI TANABE PHARMA CORPORATION
    公开号:US20160200679A1
    公开(公告)日:2016-07-14
    The present invention provides novel crystal forms of arylalkylamine compounds. Specifically, the novel crystal forms of 4-(3S-(1R-(1-naphthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid have excellent stability and therefore are useful as pharmaceutical ingredients. The present invention also provides industrially advantageous processes for producing the arylalkylamine compounds.
    本发明提供了新型芳基烷基胺化合物的晶体形式。具体地,4-(3S-(1R-(1-萘基)乙基氨基)吡咯烷-1-基)苯乙酸的新型晶体形式具有优异的稳定性,因此可以作为药用成分。本发明还提供了工业上有利的生产芳基烷基胺化合物的方法。
  • Method for Producing cis-5-hydroxy-2-piperidinecarboxylic Acid Derivative, and Method for Purifying cis-5-hydroxy-2-piperidinecarboxylic Acid
    申请人:API CORPORATION
    公开号:US20150239906A1
    公开(公告)日:2015-08-27
    The present invention aims to provide a method for purifying cis-5-hydroxy-2-piperidinecarboxylic acid with high purity, and a method for producing its derivative. The present invention provides a method for producing a cis-5-hydroxy-2-piperidinecarboxylic acid derivative, which method comprises a step of converting cis-5-hydroxy-2-piperidinecarboxylic acid into a compound(s) of Formula (1) and/or Formula (2) (wherein R 1 represents a protective group for an amino group, and R2 represents a C 1 -C 6 alkyl group), and a method for purifying cis-5-hydroxy-2-piperidinecarboxylic acid.
    本发明旨在提供一种高纯度纯化顺式-5-羟基-2-哌啶羧酸的方法,以及其衍生物的生产方法。本发明提供了一种生产顺式-5-羟基-2-哌啶羧酸衍生物的方法,该方法包括将顺式-5-羟基-2-哌啶羧酸转化为式(1)和/或式(2)化合物的步骤(其中R1代表氨基的保护基,R2代表C1-C6烷基),以及一种纯化顺式-5-羟基-2-哌啶羧酸的方法。
  • PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND
    申请人:Yamamoto Kazuhiro
    公开号:US20110034696A1
    公开(公告)日:2011-02-10
    To provide a process for producing an anthranilamide having the 3-position of pyrazole substituted by a bromine atom, or its salt. A process for producing an anthranilamide compound represented by the formula (I) or its salt: which comprises reacting a compound represented by the formula (II): (wherein Z is 2-pyridyl, 3-pyridyl, 4-pyridyl or benzene substituted by a nitro group), with a brominating agent, to produce a compound represented by the formula (III): and further reacting the compound of the formula (III) with an oxidizing agent.
    提供一种制备在吡唑的3位被溴原子取代的蒽酰胺或其盐的过程。该过程包括反应式(II)的化合物:(其中Z是2-吡啶基,3-吡啶基,4-吡啶基或被硝基取代的苯基),与溴化试剂反应,生成式(III)的化合物:进一步将式(III)的化合物与氧化剂反应,制备式(I)的蒽酰胺化合物或其盐。
  • CYCLIC AMINO COMPOUNDS
    申请人:Sankyo Company Limited
    公开号:EP1063230A1
    公开(公告)日:2000-12-27
    Cyclic amino compounds represented by general formula (I) or pharmacologically acceptable salts thereof having an excellent antiplatelet aggregation effect; etc. and thus being useful as preventives or remedies for embolism, thrombosis or arterial sclerosis wherein R1 represents optionally substituted phenyl; R2 represents optionally substituted aliphatic acyl, optionally substituted benzoyl or alkoxycarbonyl; and R3 represents substituted and optionally ring-fused saturated cyclic amino.
    通式(I)代表的环状氨基化合物或其药理上可接受的盐,具有优异的抗血小板聚集作用等,因此可作为栓塞、血栓形成或动脉硬化的预防剂或治疗剂 其中R1代表任选取代的苯基;R2代表任选取代的脂肪族酰基、任选取代的苯甲酰基或烷氧基羰基;R3代表取代的和任选环融的饱和环状氨基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐